Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Immunotherapy for sarcomas: new frontiers and unveiled opportunities.
J Immunother Cancer. 2021 Feb;9(2):e001580. doi: 10.1136/jitc-2020-001580.
J Immunother Cancer. 2021.
PMID: 33526607
Free PMC article.
Review.
The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy.
Arulanandam R, Taha Z, Garcia V, Selman M, Chen A, Varette O, Jirovec A, Sutherland K, Macdonald E, Tzelepis F, Birdi H, Alluqmani N, Landry A, Bergeron A, Vanderhyden B, Diallo JS.
Arulanandam R, et al.
Commun Biol. 2020 May 22;3(1):254. doi: 10.1038/s42003-020-0972-7.
Commun Biol. 2020.
PMID: 32444806
Free PMC article.
Item in Clipboard
Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy.
Tzelepis F, Birdi HK, Jirovec A, Boscardin S, Tanese de Souza C, Hooshyar M, Chen A, Sutherland K, Parks RJ, Werier J, Diallo JS.
Tzelepis F, et al. Among authors: birdi hk.
Mol Ther Oncolytics. 2020 Oct 14;19:240-252. doi: 10.1016/j.omto.2020.10.007. eCollection 2020 Dec 16.
Mol Ther Oncolytics. 2020.
PMID: 33209979
Free PMC article.
Item in Clipboard
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy.
Wong B, Bergeron A, Maznyi G, Ng K, Jirovec A, Birdi HK, Serrano D, Spinelli M, Thomson M, Taha Z, Alwithenani A, Chen A, Lorimer I, Vanderhyden B, Arulanandam R, Diallo JS.
Wong B, et al. Among authors: birdi hk.
Mol Ther. 2023 Nov 1;31(11):3176-3192. doi: 10.1016/j.ymthe.2023.09.017. Epub 2023 Sep 27.
Mol Ther. 2023.
PMID: 37766429
Item in Clipboard
Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment.
Surendran A, Jamalkhah M, Poutou J, Birtch R, Lawson C, Dave J, Crupi MJF, Mayer J, Taylor V, Petryk J, de Souza CT, Moodie N, Billingsley JL, Austin B, Cormack N, Blamey N, Rezaei R, McCloskey CW, Fekete EEF, Birdi HK, Neault S, Jamieson TR, Wylie B, Tucker S, Azad T, Vanderhyden B, Tai LH, Bell JC, Ilkow CS.
Surendran A, et al. Among authors: birdi hk.
Front Immunol. 2023 Mar 10;14:1099459. doi: 10.3389/fimmu.2023.1099459. eCollection 2023.
Front Immunol. 2023.
PMID: 36969187
Free PMC article.
Item in Clipboard
Cite
Cite